In my opinion, a medical cannabis company should always utilise all the available capital and resources on its core business (i.e. MM) and the participation in any "new project" implies a change of business direction, which always look like a red flag to me.
Furthermore, most people believe this COVID-19 virus is not going to last long, most likely last less than an year. So a big question for the company will be whether the change of business direction under current market environment, will be sustainable for the company in long term?
In my opinion, a medical cannabis company should always utilise...
-
- There are more pages in this discussion • 33 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
